Curanex Pharmaceuticals Inc Common Stock

CURXNASDAQ • USD
ThemeBiotech - Drug Development›Metabolic & Cardiometabolic
0.43 USD
↘ 0.01 (2.59%)AT CLOSE (11:59 AM EDT)
0.43
↗ 0.00 (0.07%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
0.43
↗ 0.00 (0.07%)
🔴Market: CLOSED
Open?$0.47
High?$0.47
Low?$0.42
Prev. Close?$0.44
Volume?81.5K
Avg. Volume?200.8K
VWAP?$0.44
Rel. Volume?0.41x
Bid / Ask
Bid?$0.35 × 100
Ask?$0.51 × 100
Spread?$0.17
Midpoint?$0.43
Valuation & Ratios
Market Cap?12.5M
Shares Out?28.4M
Float?9.1M
Float %?32.2%
P/E Ratio?N/A
P/B Ratio?1.11
EPS?-$0.15
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?81.93Strong
Quick Ratio?81.93Strong
Cash Ratio?36.29Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A▾
P/B?
1.11CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-1.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-37.7%WEAK▾
ROA?
-36.6%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$7.5M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Employees
6
Market Cap
12.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.curanexpharma.com
Listed
2025-08-26
Address
2 JERICHO PLAZA,
JERICHO, NY 11753
Phone: 718-673-6078
MarketsMoversWatchlist